Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling
about
Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic reviewThe efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2)Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policiesPrevalence of type-specific HPV among female university students from northern Brazil.Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan AfricaSignificantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.Human Papillomavirus Laboratory Testing: the Changing ParadigmShift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccinationKnowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site.Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer.[Sexually transmitted infections in Germany : The current epidemiological situation].Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.HPV vaccination: acceptance and influencing factors among young men in Germany.Sexual Behavior in Germany.[HPV-vaccination - not just for girls].Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination.Associated factors vs risk factors in cross-sectional studies.Impact of HPV vaccination with Gardasil® in Switzerland.Performance of OncoE6 cervical test with collection methods enabling self-sampling.
P2860
Q28081927-39CFEC57-78A8-4E9B-95AA-398F7D0BA907Q34241823-F20C7615-A889-414E-B6C2-92A156B11069Q34411111-072946BF-BF8B-4415-A3D6-8ED12000C078Q34897737-DEE27170-0842-4E09-B6B3-F755672B0518Q35879158-C24C0EDE-19FB-4D16-8867-41072E4B4799Q35887646-82E32336-844D-4D27-AA2B-627E18E06675Q36092294-87D595E7-7927-46E0-AD5B-385D99753E23Q36675236-FF840274-D3FD-4A10-8C7D-8D40CB947ADDQ37002753-637E3090-8A22-4D8C-B181-5F660486769DQ37159683-21C7E67F-8020-4AF7-8690-154A81A9E024Q37214524-577293EB-12E6-4FC3-9FF6-8B764B4C1EF9Q37833750-2A3B9480-15F9-404C-B250-5B6C78F4C5B3Q38229304-DB9DD171-3C90-41A2-AD53-AC0DAFCB7A33Q38586257-8BDF8E6E-9C4E-4778-8621-E9E31D122CA4Q38723059-30798376-CA98-4D3D-A163-A25302FB3236Q38931505-D787FC95-C7F8-41D1-BBCA-8E9749A7BF59Q40074217-BD9B096A-9AD1-479F-A642-7BB9D4B59835Q41201908-B455C82C-C2A4-4A18-AD2A-87FBA2726198Q41672842-0794D667-487F-4B60-81AB-6A4BA24416BBQ41810973-140DFECA-9EE1-4117-AA39-A620AACD2519Q47257772-2C00AD31-B9DF-4FCB-A229-C4AAC00941E8Q55261992-4B1E614C-613E-4C11-BF2D-6BBE33289B40
P2860
Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Human Papillomavirus prevalenc ...... y via home-based self-sampling
@ast
Human Papillomavirus prevalenc ...... y via home-based self-sampling
@en
type
label
Human Papillomavirus prevalenc ...... y via home-based self-sampling
@ast
Human Papillomavirus prevalenc ...... y via home-based self-sampling
@en
prefLabel
Human Papillomavirus prevalenc ...... y via home-based self-sampling
@ast
Human Papillomavirus prevalenc ...... y via home-based self-sampling
@en
P2093
P2860
P356
P1476
Human Papillomavirus prevalenc ...... y via home-based self-sampling
@en
P2093
Achim Schneider
Andreas M Kaufmann
Cornelius Remschmidt
Josefine Leuschner
Melanie Schuster
Michaela Fesenfeld
Yvonne Deleré
P2860
P2888
P356
10.1186/1471-2334-14-87
P50
P577
2014-02-19T00:00:00Z
P5875
P6179
1029973072